Influenza Vaccination Induces NK-Cell-Mediated Type-II IFN Response that Regulates Humoral Immunity in an IL-6-Dependent Manner.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
26 02 2019
Historique:
received: 06 02 2018
revised: 11 12 2018
accepted: 28 01 2019
entrez: 28 2 2019
pubmed: 28 2 2019
medline: 17 4 2020
Statut: ppublish

Résumé

The role of natural killer (NK) cells in the immune response against vaccines is not fully understood. Here, we examine the function of infiltrated NK cells in the initiation of the inflammatory response triggered by inactivated influenza virus vaccine in the draining lymph node (LN). We observed that, following vaccination, NK cells are recruited to the interfollicular and medullary areas of the LN and become activated by type I interferons (IFNs) produced by LN macrophages. The activation of NK cells leads to their early production of IFNγ, which in turn regulates the recruitment of IL-6+ CD11b+ dendritic cells. Finally, we demonstrate that the interleukin-6 (IL-6)-mediated inflammation is important for the development of an effective humoral response against influenza virus in the draining LN.

Identifiants

pubmed: 30811982
pii: S2211-1247(19)30141-X
doi: 10.1016/j.celrep.2019.01.104
pii:
doi:

Substances chimiques

Influenza Vaccines 0
Interferon Type I 0
Interleukin-6 0
interleukin-6, mouse 0
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2307-2315.e5

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Yagmur Farsakoglu (Y)

Institute for Research in Biomedicine (IRB), Università della Svizzera italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland; Graduate School of Cellular and Molecular Sciences, Faculty of Medicine, University of Bern, 3012 Bern, Switzerland.

Miguel Palomino-Segura (M)

Institute for Research in Biomedicine (IRB), Università della Svizzera italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland; Graduate School of Cellular and Molecular Sciences, Faculty of Medicine, University of Bern, 3012 Bern, Switzerland.

Irene Latino (I)

Institute for Research in Biomedicine (IRB), Università della Svizzera italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland.

Silvia Zanaga (S)

Institute for Research in Biomedicine (IRB), Università della Svizzera italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland.

Nikolaos Chatziandreou (N)

Institute for Research in Biomedicine (IRB), Università della Svizzera italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland.

Diego Ulisse Pizzagalli (DU)

Institute for Research in Biomedicine (IRB), Università della Svizzera italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland; Institute of Computational Science (ICS), Università della Svizzera italiana, Via Giuseppe Buffi 13, 6900 Lugano, Switzerland.

Andrea Rinaldi (A)

Institute of Oncology Research (IOR), Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland.

Marco Bolis (M)

Institute of Oncology Research (IOR), Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland; Laboratory of Molecular Biology, Instituto di Ricerche Farmacologiche Mario Negri IRCCS, via Giuseppe La Masa 19, 20156 Milano, Italy.

Federica Sallusto (F)

Institute for Research in Biomedicine (IRB), Università della Svizzera italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland; Institute for Microbiology, ETH Zurich, Wolfgang-Pauli-Strasse 10, 8093 Zurich, Switzerland.

Jens V Stein (JV)

Theodor Kocher Institute (TKI), University of Bern, Freiestrasse 1, 3000 Bern, Switzerland.

Santiago F Gonzalez (SF)

Institute for Research in Biomedicine (IRB), Università della Svizzera italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland. Electronic address: santiago.gonzalez@irb.usi.ch.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH